Furthermore, Youn found that SGLT2 inhibitors not only reduced the incidence of dementia but also improved cognitive outcomes, particularly in individuals with mild cognitive impairment or previously diagnosed dementia [147]. The gene discussed is SLC5A2; the disease is dementia.